137 related articles for article (PubMed ID: 24845411)
1. Patterns of presentation and failure in patients with gliomatosis cerebri treated with partial-brain radiation therapy.
Kandula S; Saindane AM; Prabhu RS; Hanasoge S; Patel KR; Shu HK; Curran WJ; Crocker IR
Cancer; 2014 Sep; 120(17):2713-20. PubMed ID: 24845411
[TBL] [Abstract][Full Text] [Related]
2. Gliomatosis cerebri having a poor performance status without recurrence after radiotherapy: a single institutional experience.
Jung TY; Yoon MS; Kim YH; Jung S; Kim IY; Jang WY; Moon KS; Lee KH; Kim SK
Clin Neurol Neurosurg; 2015 Mar; 130():1-5. PubMed ID: 25569296
[TBL] [Abstract][Full Text] [Related]
3. Gliomatosis cerebri: treatment results with radiotherapy alone.
Elshaikh MA; Stevens GH; Peereboom DM; Cohen BH; Prayson RA; Lee SY; Barnett GH; Suh JH
Cancer; 2002 Nov; 95(9):2027-31. PubMed ID: 12404298
[TBL] [Abstract][Full Text] [Related]
4. Procarbazine and CCNU as initial treatment in gliomatosis cerebri.
Glas M; Rasch K; Wiewrodt D; Weller M; Herrlinger U
Oncology; 2008; 75(3-4):182-5. PubMed ID: 18841032
[TBL] [Abstract][Full Text] [Related]
5. Initial chemotherapy in gliomatosis cerebri.
Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
[TBL] [Abstract][Full Text] [Related]
6. NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.
Glas M; Bähr O; Felsberg J; Rasch K; Wiewrodt D; Schabet M; Simon M; Urbach H; Steinbach JP; Rieger J; Fimmers R; Bamberg M; Nägele T; Reifenberger G; Weller M; Herrlinger U;
Ann Neurol; 2011 Sep; 70(3):445-53. PubMed ID: 21710625
[TBL] [Abstract][Full Text] [Related]
7. Gliomatosis cerebri: improved outcome with radiotherapy.
Perkins GH; Schomer DF; Fuller GN; Allen PK; Maor MH
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1137-46. PubMed ID: 12829152
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
9. [Gliomatosis cerebri: report of 3 cases and review of recent literatures].
Arai M; Kashihara K; Kaizaki Y; Taguchi M; Kitamura Y
No To Shinkei; 2003 Oct; 55(10):890-7. PubMed ID: 14635518
[TBL] [Abstract][Full Text] [Related]
10. Gliomatosis cerebri: clinical characteristics, management, and outcomes.
Chen S; Tanaka S; Giannini C; Morris J; Yan ES; Buckner J; Lachance DH; Parney IF
J Neurooncol; 2013 Apr; 112(2):267-75. PubMed ID: 23341100
[TBL] [Abstract][Full Text] [Related]
11. Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.
Carroll KT; Hirshman B; Ali MA; Alattar AA; Brandel MG; Lochte B; Lanman T; Carter B; Chen CC
World Neurosurg; 2017 Jul; 103():186-193. PubMed ID: 28366748
[TBL] [Abstract][Full Text] [Related]
12. [Gliomatosis cerebri: review of 22 patients].
Novillo López ME; Gómez-Ibáñez A; Rosenfeld M; Dalmau J
Neurologia; 2010 Apr; 25(3):168-73. PubMed ID: 20492863
[TBL] [Abstract][Full Text] [Related]
13. Exclusive radiotherapy for gliomatosis cerebri: long-term follow-up at a single institution.
Kim K; Chie EK; Park HJ; Kim DG; Jung HW; Park SH; Kim IH
Clin Transl Oncol; 2014 Sep; 16(9):829-33. PubMed ID: 24474572
[TBL] [Abstract][Full Text] [Related]
14. Gliomatosis cerebri treatment in 11 elderly patients.
Piccirilli M; Landi A; Salvati M
J Exp Clin Cancer Res; 2006 Jun; 25(2):183-7. PubMed ID: 16918128
[TBL] [Abstract][Full Text] [Related]
15. Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri.
Kaloshi G; Guillevin R; Martin-Duverneuil N; Laigle-Donadey F; Psimaras D; Marie Y; Mokhtari K; Hoang-Xuan K; Delattre JY; Sanson M
Neurology; 2009 Aug; 73(6):445-9. PubMed ID: 19667319
[TBL] [Abstract][Full Text] [Related]
16. Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.
Mattox AK; Lark AL; Adamson DC
Clin Neurol Neurosurg; 2012 May; 114(4):299-306. PubMed ID: 22341931
[TBL] [Abstract][Full Text] [Related]
17. Impact of adjuvant chemotherapy for gliomatosis cerebri.
Kong DS; Kim ST; Lee JI; Suh YL; Lim DH; Kim WS; Kwon KH; Park K; Kim JH; Nam DH
BMC Cancer; 2010 Aug; 10():424. PubMed ID: 20704759
[TBL] [Abstract][Full Text] [Related]
18. Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia.
Armstrong GT; Phillips PC; Rorke-Adams LB; Judkins AR; Localio AR; Fisher MJ
Cancer; 2006 Oct; 107(7):1597-606. PubMed ID: 16955507
[TBL] [Abstract][Full Text] [Related]
19. [Gliomatosis cerebri].
Sanson M; Napolitano M; Cartalat-Carel S; Taillibert S
Rev Neurol (Paris); 2005 Feb; 161(2):173-81. PubMed ID: 15798516
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and results of treatment with radiation therapy in gliomatosis cerebri patient: case report.
Sun LM; Lui CC; Huang SC; Lu K; Wang CJ
Chang Gung Med J; 2001 Mar; 24(3):196-201. PubMed ID: 11355088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
